| 产品描述： | XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM. |
| 靶点： |
ERK5:162 nM (IC50);LRRK2[G2019S]:339 nM (IC50);ERK |
| 参考文献： |
1. Deng X, et al. Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones. Eur J Med Chem. 2013;70:758-67. 2. Elkins, Jonathan M., et al. X-ray Crystal Structure of ERK5 (MAPK7) in Complex with a Specific Inhibitor. Journal of Medicinal Chemistry (2013), 56(11), 4413-4421. 3. Wilhelmsen K, et al. Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation. Sci Signal. 2015 Aug 25;8(391):ra86. |
| 溶解性： |
DMSO : ≥ 100 mg/mL (156.54 mM) |
| 保存条件： |
-20℃ |
| 配置溶液浓度参考： |
|
1mg |
5mg |
10mg |
| 1 mM |
1.565 ml |
7.827 ml |
15.654 ml |
| 5 mM |
0.313 ml |
1.565 ml |
3.131 ml |
| 10 mM |
0.157 ml |
0.783 ml |
1.565 ml |
| 50 mM |
0.031 ml |
0.157 ml |
0.313 ml |
|
| 注意： |
部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京